Sheets Smith Investment Management’s CalciMedica CALC Stock Holding History

Sheets Smith Investment Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$157K	Buy	+51,100	New	+$147K	0.1%	128

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Sheets Smith Investment Management's CALC Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in CalciMedica (CALC) in Q3 2025: 51,100 shares worth $157K. The stake represents 0.1% of the portfolio and ranks #128 among its holdings.

31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

Sheets Smith Investment Management held 51,100 shares of CalciMedica worth $157K as of Q3 2025.
CalciMedica was a new Sheets Smith Investment Management position in Q3 2025.
CalciMedica made up 0.1% of Sheets Smith Investment Management's portfolio in Q3 2025, its #128 holding.
31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.